Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study. (Q51332473)
Jump to navigation
Jump to search
scientific article published on 21 October 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study. |
scientific article published on 21 October 2013 |
Statements
1 reference
Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study. (English)
1 reference
Serge A Jabbour
1 reference
Elise Hardy
1 reference
Jennifer Sugg
1 reference
Shamik Parikh
1 reference
Study 10 Group
1 reference
21 October 2013
1 reference
1 reference
37
1 reference
740-750
1 reference
3
1 reference
Identifiers
1 reference
1 reference